Repligen | RGEN - 现金及等价物

金融业

USD

USD 2.95B

现金及等价物

USD 566.02M

USD 94.08M

USD 1.14B

USD 135.83M

USD 542.21M

USD 19.97M

USD 39.54M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 103.83M

债务利息支出

USD 5.5M

USD 7.31M

USD 542.21M

USD 7.12B

USD 13.29M

USD 177.95M

USD 19.97M

普通股股本

USD 56.33M

164.06

USD 19.11M

USD 194M

销售和管理费用

USD 74.36M

USD 170.46M

贸易债权人

USD 30.01M

应收帐款人

USD 158.59M

	现金及等价物	更改		日
Agilent	USD 1.76B		31M	2025-12
Align Technology	USD 1.09B		90.32M	2025-12
Bio Techne	USD 172.88M		27.92M	2025-12
BioMarin Pharmaceutical	USD 2.22B		910.76M	2026-03
Bristol-Myers Squibb	USD 9.57B		635M	2026-03
Bruker	USD 293.1M		201.1M	2025-09
Charles River Laboratories	USD 213.77M		6.67M	2025-12
Danaher	USD 5.7B		1.09B	2026-03
Dentsply International	USD 190M		136M	2026-03
General Electric Aerospace	USD 10.98B		1.41B	2026-03
Henry Schein	USD 156M		20M	2025-12
Illumina	USD 1.42B		368M	2025-12
IQVIA Holdings	USD 1.95B		33M	2026-03
Mettler Toledo International	USD 69.06M		7.24M	2025-09
Myriad Genetics	USD 149.6M		4.2M	2025-12
OraSure Technologies	USD 199.28M		17.2M	2025-12
Pacific Biosciences Of California	USD 279.51M		223.04M	2025-12
Pfizer	USD 1.7B		561M	2026-03
Repligen	USD 566.02M		182.73M	2025-12
Revvity	USD 919.86M		11.53M	2025-12
Standard Biotools	USD 118.21M		11.2M	2025-12
Thermo Fisher Scientific	USD 3.25B		6.6B	2026-03
Waters	USD 587.83M		128.71M	2025-12
West Pharmaceutical Services	USD 521.4M		269.9M	2026-03